In our study, we demonstrate that GSK3 inhibitors could sensitize certain gastric adenocarcinoma cells to TRAIL-induced apoptosis by increasing caspase-8 activity and its downstream signal transmission. Here, CASP8 is linked to gastric adenocarcinoma.